| abstract |
Remedies for cerebral ischemic diseases, which contain substances having human leukocyte elastase inhibitory activities as the active ingredient. Particular examples of such substances include WS7622A mono- and disulfates, medicinally acceptable salts thereof, trifluoromethyl ketone derivatives such as 3(RS)-[ [4-(carboxymethylaminocarbonyl)phenylcarbonyl] -L-valyl-L-propyl] amino-1,1,1-trifluoro-4-methyl-2-oxopentane, and medicinally acceptable salts thereof. |